Your browser doesn't support javascript.
loading
CVLT-II short form forced choice recognition in a clinical dementia sample: Cautions for performance validity assessment.
Grewal, Karl S; Trites, Michaella; Kirk, Andrew; MacDonald, Stuart W S; Morgan, Debra; Gowda-Sookochoff, Rory; O'Connell, Megan E.
Afiliação
  • Grewal KS; Department of Psychology, University of Saskatchewan, Saskatoon, Canada.
  • Trites M; Department of Psychology, University of Victoria, Victoria, Canada.
  • Kirk A; Department of Medicine, University of Saskatchewan, Saskatoon, Canada.
  • MacDonald SWS; University of Victoria, Victoria, Canada.
  • Morgan D; Canadian Centre for Health and Safety in Agriculture, University of Saskatchewan, Saskatoon, Canada.
  • Gowda-Sookochoff R; Department of Psychology, University of Saskatchewan, Saskatoon, Canada.
  • O'Connell ME; Department of Psychology, University of Saskatchewan, Saskatoon, Canada.
Appl Neuropsychol Adult ; : 1-10, 2022 May 30.
Article em En | MEDLINE | ID: mdl-35635794
Performance validity tests are susceptible to false positives from genuine cognitive impairment (e.g., dementia); this has not been explored with the short form of the California Verbal Learning Test II (CVLT-II-SF). In a memory clinic sample, we examined whether CVLT-II-SF Forced Choice Recognition (FCR) scores differed across diagnostic groups, and how the severity of impairment [Clinical Dementia Rating Sum of Boxes (CDR-SOB) or Mini-Mental State Examination (MMSE)] modulated test performance. Three diagnostic groups were identified: subjective cognitive impairment (SCI; n = 85), amnestic mild cognitive impairment (a-MCI; n = 17), and dementia due to Alzheimer's Disease (AD; n = 50). Significant group differences in FCR were observed using one-way ANOVA; post-hoc analysis indicated the AD group performed significantly worse than the other groups. Using multiple regression, FCR performance was modeled as a function of the diagnostic group, severity (MMSE or CDR-SOB), and their interaction. Results yielded significant main effects for MMSE and diagnostic group, with a significant interaction. CDR-SOB analyses were non-significant. Increases in impairment disproportionately impacted FCR performance for persons with AD, adding caution to research-based cutoffs for performance validity in dementia. Caution is warranted when assessing performance validity in dementia populations. Future research should examine whether CVLT-II-SF-FCR is appropriately specific for best-practice testing batteries for dementia.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Appl Neuropsychol Adult Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Appl Neuropsychol Adult Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos